Events
September 29, 2022
Webcast - Validation of an in vitro α-synuclein aggregation assay for target discovery in neurodegenerative disease research
Event info: In this webcast, Paul Karila, Head of Drug Discovery, and Johan Pihl, Chief Operating Officer, discuss the development...
Events
September 19-23, 2022
World Congress on Pain
The IASP 2022 World Congress on Pain takes place in Toronto, Canada and online on September 19-23, 2022. At the...
Events
May 16-17, 2022
Neuro4D
The Neuro4D conference takes place in Mainz, Germany on May 16-17, 2022. With a focus on neurodegenerative disease drug discovery,...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

Events
May 10-12, 2022
Advances in Cell-based Screening
ELRIG’s meeting on Advances in Cell-based Screening 2022 takes place at AstraZeneca in Gothenburg, Sweden on May 10-12, 2022. The...
Events
May 8-10, 2022
Target to Patient
The Target to Patient meeting takes place at the Wellcome Genome Campus in Hinxton, UK on May 8-10, 2022. The...
Events
March 15-20, 2022
AD/PD 2022
The AD/PD™ 2022 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders took place in Barcelona, Spain and...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

Events
November 8-11, 2021
Neuroscience 2021
The Neuroscience 2021 takes place on November 8-11 as a virtual meeting. During the conference, we will present several posters...
News
2021-06-03
Cellectricon receives funding from Takeda’s open innovation platform
March 3, 2021 Cellectricon, a leading provider of neurobiology in vitro research services, is delighted to announce the initiation of...
Events
June 17, 2021
Webcast - The importance of non-neuronal cells in chronic pain – a Drug Discovery perspective
Event info: Pain drug discovery has historically been challenging with few new therapeutics reaching the market. In this webcast, Cellectricon...